Exclusive special offer and discount title banner vector image

GLOBAL 3D BIOPRINTING MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Global 3D Bioprinting Market by Component (3d Bioprinter, Bioink) Market by Biomaterial (Hydrogel, Living Cells, Extracellular Matrices, Other Biomaterials) Market by Technology (Magnetic Levitation Bioprinting, Inkjet-based Bioprinting, Syringe/extrusion-based Bioprinting, Laser-assisted Bioprinting, Other Technologies) Market by Application (Drug Testing & Development, Tissue Engineering & Regenerative Medicine, Food Testing, Research, Other Applications) Market by End-user (Hospitals, Biopharmaceuticals Companies, Research Organizations and Academic Institutes, Other End-users) by Geography


MARKET OVERVIEW

The global 3D bioprinting market was valued at $1245.95 million in 2022 and is expected to reach $5693.82 million by 2032, growing at a CAGR of 16.69% during the forecast period, 2023-2032

In 3D bioprinting, living cells and nutrients are used instead of conventional metals and plastics to generate synthetic structures that resemble natural human tissues. It can produce everything from bone tissues and blood vessels to functional 3D living tissues for various medical purposes, including tissue engineering and drug testing & development.

With regard to pharmaceuticals, 3D bioprinting offers a quicker, less expensive, and more biologically relevant method of testing medications than animal testing. Biomedical devices have witnessed major advancements due to 3D bioprinting, including enhanced drug delivery systems and sugar stents that allow surgeons to join veins with less difficulty. With advancements in bioprinting, printing organ patches, skin & bone grafts, and whole replacement organs will eventually be feasible using a patient’s cells.

Read our latest blog on the 3D Bioprinting Market

GROWTH ENABLERS

Key growth enablers of the global 3D bioprinting market are: 

  • Surging geriatric population
    • According to World Population Prospects data, adults aged 60 or above are predicted to more than quadruple by 2050. It is expanding faster than other age groups globally, including the young population.
    • Population aging and the associated increased incidence of bone fractures, osteoarthritis, osteoporosis, and obesity contribute significantly to the failure of orthopedic implants.
    • Besides, the rising geriatric population and their vulnerability to chronic illnesses like cardiovascular, musculoskeletal, and other ailments offer growth opportunities. 
    • For instance, the necessity for 3D bioprinted bone will only grow in the upcoming years since it can be customized to patient-specific requirements.
  • Technological advancements and R&D investments
  • Rising focus on regenerative medicine
  • High prevalence of chronic conditions

GROWTH RESTRAINTS

Key growth restraining factors of the global 3D bioprinting market are:

  • Operational challenges during manufacturing
  • Exorbitant costs of 3D bioprinters
    • Materials, labor, tooling expenses, and post-processing charges are the four main cost categories of additive manufacturing methods like 3D bioprinting.
    • The economic efficiency of 3D bioprinting must also be considered, especially in light of the expensive nature of 3D printers, cellular materials, and computer software.
    • Overall, it is difficult to introduce 3D printing capabilities to laboratories due to the costs of maintenance and extension of bioprinting technology. 
  • Lack of trained professionals

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global 3D Bioprinting Market | Top Market Trends

  • Due to the lack of organ donors, high costs, and immunological difficulties that limit the accessibility & clinical efficacy of organ transplantation worldwide, the use of tissue-engineered pharmaceutical products (TEMPs) is on the rise. Similarly, artificial organ creation using tissue engineering techniques is required. Hence, tissue-engineered pharmaceutical products (TEMPs) are utilized to create engineered tissues and are viewed as drugs for treating human disease or injury using genes, tissues, or cells.
  • Using tissues produced from patients’ cells, 3D bioprinting facilitates the creation of functional organs like bladders, which have already been successfully implanted into human bodies. The potential for printing other functional organs is a topic of ongoing research. In April 2019, the first vascularized 3D-printed tiny heart created by Tel Aviv University’s Faculty of Molecular Cell Biology and Biotechnology was featured in news outlets. 
  • According to reports, 3D bioprinting uses various biomaterials like bioinks. Pathways for developing bioinks have been facilitated by recent developments in the utilization of supramolecular and dynamic covalent chemistry (DCvC). The production of more realistic settings for ultimate tissue maturation is made possible by these dynamic hydrogels, which also permit tailorability and better printing performance. Nowadays, many bioink formulations rely on the light-triggered polymerization of PEGDA or GelMA or the quick Ca2+ cross-linking of alginate.

MARKET SEGMENTATION

Market Segmentation – Component, Biomaterial, Technology, Application, and End-User –

Market by Component:

  • 3D Bioprinter
    • 3D bioprinter is the largest revenue-generating component in the market.
    • Most 3D bioprinters can be purchased commercially. However, some of them are only used in research. Both purposes are served by the products of some companies, such as Poietis. They have created the NGB-R model exclusively for research applications.
    • In contrast, the NGB-C is a clinical-grade, GMP-compliant bioprinter primarily geared toward manufacturing and clinical applications. Both of them use a laser to assist in the bioprinting process.
    • Moreover, 3D bioprinters are undergoing advancements, thereby increasing their demand among end-users. The most recent one is the Handheld 3D Bioprinter (February 2020) which can heal severe skin burns. The tool applies sheets of material made from a bioink to the wound, accelerating the skin’s healing process.
  • Bioink

Market by Biomaterial:

  • Hydrogel
    • Hydrogel is the fastest-growing biomaterial. 
    • Due to their great compatibility, hydrogels are frequently employed in the 3D bioprinting process. Moreover, hydrogels mimic the body’s soft tissues, swelling to high levels in water and behaving mechanically similar to biological soft tissues.
    • Hydrogels are also extensively used as a matrix in the medical industry to encapsulate 3D bioprinter cells and restore & replace many damaged soft tissues and organs.
    • A wide selection of hydrogel biomaterials is available from a number of providers in the market. It is anticipated that the availability of hydrogel-printing bioprinters from several bioprinting businesses, including Organovo Holdings, will accelerate the growth of hydrogels for 3D bioprinting over the projected period.
  • Living Cells
  • Extracellular Matrices
  • Other Biomaterials

Market by Technology:

  • Magnetic Levitation Bioprinting 
  • Inkjet-Based Bioprinting
  • Syringe/Extrusion-Based Bioprinting
  • Laser-Assisted Bioprinting
  • Other Technologies

Market by Application:

  • Drug Testing & Development
  • Tissue Engineering & Regenerative Medicine
  • Food Testing
  • Research
  • Other Applications

Market by End-User:

  • Hospitals
  • Biopharmaceuticals Companies
  • Research Organizations and Academic Institutes
  • Other End-Users

GEOGRAPHICAL STUDY

Geographical Study Based on Four Major Regions:
  • North America: The United States and Canada
    • North America is the dominating region in the global market. 
    • A significant factor driving the regional market is the increasing number of elderly patients in North America. The US Census predicts that by 2030, there will be more individuals aged above 65 than there are children.
    • Most bioprinting producers are based in the North American continent, including renowned vendors like Organovo and Advanced Solutions.
    • The United States, one of the forerunners in adopting 3D bioprinting, is anticipated to have a significant market share. 
    • In May 2021, scientists at the University of Alberta created personalized cartilage for reconstructive surgery using a specially created hydrogel and patient cells. The cartilage was then manufactured in a specified arrangement using 3D imaging.
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Nordic Countries, and Rest of Europe
  • Asia-Pacific: China, India, Japan, South Korea, Singapore, Thailand, Australia & New Zealand, and Rest of Asia-Pacific
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

Some of the major players in the global 3D bioprinting market are:

  • CollPlant 
  • REGEMAT 3D 
  • GeSiM GmbH 
  • Cyfuse Biomedical KK 
  • Advanced Solutions Life Sciences 

Key strategies adopted by some of these companies:

  • In February 2023, the first monolithic, full-color 3D printed permanent dentures product, TrueDentTM, was introduced by Stratasys Ltd. With the help of the TrueDent resin, labs can produce gums that are permanent, realistic-looking, and exact in terms of tooth structure, tint, and translucency in a single continuous print.
  • In February 2023, Inventia Life Science announced a partnership with MSD – a trademark of Merck & Co Inc, the United States, with regard to Inventia’s RASTRUMTM 3D cell culture technology. Under this partnership, RASTRUMTM’s cutting-edge bioprinting capabilities will be used to build 3D in vitro models for the preclinical testing of potential treatments for neurodegenerative diseases.
  • In October 2022, Stratasys Ltd announced the acquisition of Riven, a quality assurance software provider and a Stratasys connectivity software partner. Consumers using any Stratasys 3D printer running GrabCAD Print software will benefit from the software solution fully integrated into Stratasys’ GrabCAD® Additive Manufacturing Platform. 
  • In July 2022, to create an infertility-detecting IVD device, CELLINK and Spermosens AB, Malmö University, and SLU signed a cooperative agreement.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedComponent, Biomaterial, Technology, Application & End-User
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed3D Bioprinting Solutions, Advanced Solutions Life Sciences, Allevi, CELLINK, CollPlant Biotechnologies Ltd, Cyfuse Biomedical KK, EnvisionTEC Ṁ Inc, GeSiM GmbH, Inventia Life Science Pty Ltd, Organovo Holdings Inc, Regemat 3D, REGENHU, Revotek Co Ltd, ROKIT Healthcare Inc, Stratasys Ltd

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
    5. MAJOR MARKET FINDINGS
      1. EMERGENCE OF 4D BIOPRINTING AS A SUBSTITUTE FOR 3D BIOPRINTING
      2. PERSONALIZED MEDICINE LIKELY TO BOOST 3D BIOPRINTING
      3. RISING INTEREST IN THE APPLICATION OF BIOPRINTING AGAINST THE SARS-COV-2 VIRUS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SURGING GERIATRIC POPULATION
      2. TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENTS
      3. RISING FOCUS ON REGENERATIVE MEDICINE
      4. HIGH PREVALENCE OF CHRONIC CONDITIONS
    2. KEY RESTRAINTS
      1. OPERATIONAL CHALLENGES DURING MANUFACTURING
      2. EXORBITANT COSTS OF 3D BIOPRINTERS
      3. LACK OF TRAINED PROFESSIONALS 
  4. KEY ANALYTICS
    1. PARENT MARKET ANALYSIS
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING IN UNITED STATES
      2. GROWTH PROSPECT MAPPING IN GERMANY
      3. GROWTH PROSPECT MAPPING IN CHINA
      4. GROWTH PROSPECT MAPPING FOR BRAZIL
    5. MARKET MATURITY ANALYSIS
    6. MARKET CONCENTRATION ANALYSIS
    7. VALUE CHAIN ANALYSIS
      1. DESIGN & SOFTWARE PROVIDERS
      2. PROTOTYPE PRODUCTION
      3. DISTRIBUTION
      4. END-USERS
  5. MARKET BY COMPONENT
    1. 3D BIOPRINTER
    2. BIOINK
  6. MARKET BY BIOMATERIAL
    1. HYDROGEL
    2. LIVING CELLS
    3. EXTRACELLULAR MATRICES
    4. OTHER BIOMATERIALS
  7. MARKET BY TECHNOLOGY
    1. MAGNETIC LEVITATION BIOPRINTING
    2. INKJET-BASED BIOPRINTING
    3. SYRINGE/EXTRUSION-BASED BIOPRINTING
    4. LASER-ASSISTED BIOPRINTING
    5. OTHER TECHNOLOGIES
  8. MARKET BY APPLICATION
    1. DRUG TESTING & DEVELOPMENT
    2. TISSUE ENGINEERING & REGENERATIVE MEDICINE
    3. FOOD TESTING
    4. RESEARCH
    5. OTHER APPLICATIONS
  9. MARKET BY END-USER
    1. HOSPITALS
    2. BIOPHARMACEUTICALS COMPANIES
    3. RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
    4. OTHER END-USERS
  10. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA 3D BIOPRINTING MARKET DRIVERS
      3. NORTH AMERICA 3D BIOPRINTING MARKET CHALLENGES
      4. NORTH AMERICA 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA 3D BIOPRINTING MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE 3D BIOPRINTING MARKET DRIVERS
      3. EUROPE 3D BIOPRINTING MARKET CHALLENGES
      4. EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE 3D BIOPRINTING MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        6. NORDIC COUNTRIES
          1. NORDIC COUNTRIES 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        7. REST OF EUROPE
          1. REST OF EUROPE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC 3D BIOPRINTING MARKET DRIVERS
      3. ASIA-PACIFIC 3D BIOPRINTING MARKET CHALLENGES
      4. ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC 3D BIOPRINTING MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        5. SINGAPORE
          1. SINGAPORE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        7. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        8. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD 3D BIOPRINTING MARKET DRIVERS
      3. REST OF WORLD 3D BIOPRINTING MARKET CHALLENGES
      4. KEY PLAYERS IN REST OF WORLD 3D BIOPRINTING MARKET
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
    2. COMPANY PROFILES
      1. 3D BIOPRINTING SOLUTIONS
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
      2. ADVANCED SOLUTIONS LIFE SCIENCES
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
      3. ALLEVI
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
      4. CELLINK
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      5. COLLPLANT BIOTECHNOLOGIES LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
      6. CYFUSE BIOMEDICAL KK
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      7. ENVISIONTEC ṁ INC
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      8. GESIM GMBH
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      9. INVENTIA LIFE SCIENCE PTY LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
      10. ORGANOVO HOLDINGS INC
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      11. REGEMAT 3D
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      12. REGENHU
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
        3. STRENGTHS & CHALLENGES
      13. REVOTEK CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
      14. ROKIT HEALTHCARE INC
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST
      15. STRATASYS LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS LIST

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – 3D BIOPRINTING

TABLE 2: COMPARATIVE SUMMARY OF 3D BIOPRINTING TECHNOLOGIES

TABLE 3: LIST OF APPROVED TISSUE-ENGINEERED MEDICAL PRODUCTS (TEMPS) USED IN VARIOUS COUNTRIES

TABLE 4: GLOBAL 3D BIOPRINTING MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL 3D BIOPRINTING MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: GLOBAL 3D BIOPRINTER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL 3D BIOPRINTER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: GLOBAL BIOINK MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL BIOINK MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: GLOBAL 3D BIOPRINTING MARKET, BY BIOMATERIAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL 3D BIOPRINTING MARKET, BY BIOMATERIAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: GLOBAL HYDROGEL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL HYDROGEL MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 14: GLOBAL LIVING CELLS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL LIVING CELLS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 16: GLOBAL EXTRACELLULAR MATRICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL EXTRACELLULAR MATRICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 18: GLOBAL OTHER BIOMATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL OTHER BIOMATERIALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 20: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 22: GLOBAL MAGNETIC LEVITATION BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL MAGNETIC LEVITATION BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 24: GLOBAL INKJET-BASED BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL INKJET-BASED BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 26: GLOBAL SYRINGE/EXTRUSION-BASED BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL SYRINGE/EXTRUSION-BASED BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 28: GLOBAL LASER-ASSISTED BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: GLOBAL LASER-ASSISTED BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 30: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 31: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 32: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 34: GLOBAL DRUG TESTING & DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 35: GLOBAL DRUG TESTING & DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 36: GLOBAL TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: GLOBAL TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 38: GLOBAL FOOD TESTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 39: GLOBAL FOOD TESTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 40: GLOBAL RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: GLOBAL RESEARCH MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 42: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 43: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 44: GLOBAL 3D BIOPRINTING MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 45: GLOBAL 3D BIOPRINTING MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 46: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 47: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 48: GLOBAL BIOPHARMACEUTICALS COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 49: GLOBAL BIOPHARMACEUTICALS COMPANIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 50: GLOBAL RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 51: GLOBAL RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 52: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 53: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 54: GLOBAL 3D BIOPRINTING MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 55: GLOBAL 3D BIOPRINTING MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 56: NORTH AMERICA 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 57: NORTH AMERICA 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 58: NORTH AMERICA 3D BIOPRINTING MARKET REGULATORY FRAMEWORK

TABLE 59: KEY PLAYERS OPERATING IN NORTH AMERICA 3D BIOPRINTING MARKET

TABLE 60: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 61: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 62: EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK

TABLE 63: KEY PLAYERS OPERATING IN EUROPE 3D BIOPRINTING MARKET

TABLE 64: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 65: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 66: ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK

TABLE 67: KEY PLAYERS OPERATING IN ASIA-PACIFIC 3D BIOPRINTING MARKET

TABLE 68: REST OF WORLD 3D BIOPRINTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 69: REST OF WORLD 3D BIOPRINTING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 70: KEY PLAYERS OPERATING IN REST OF WORLD 3D BIOPRINTING MARKET

TABLE 71: LIST OF MERGERS & ACQUISITIONS

TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 73: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY

FIGURE 5: GROWTH PROSPECT MAPPING FOR CHINA

FIGURE 6: GROWTH PROSPECT MAPPING FOR BRAZIL

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: VALUE CHAIN ANALYSIS

FIGURE 10: GLOBAL 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022

FIGURE 11: GLOBAL 3D BIOPRINTING MARKET, BY 3D BIOPRINTER, 2023-2032 (IN $ MILLION)

FIGURE 12: GLOBAL 3D BIOPRINTING MARKET, BY BIOINK, 2023-2032 (IN $ MILLION)

FIGURE 13: GLOBAL 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY BIOMATERIAL, IN 2022

FIGURE 14: GLOBAL 3D BIOPRINTING MARKET, BY HYDROGEL, 2023-2032 (IN $ MILLION)

FIGURE 15: GLOBAL 3D BIOPRINTING MARKET, BY LIVING CELLS, 2023-2032 (IN $ MILLION)

FIGURE 16: GLOBAL 3D BIOPRINTING MARKET, BY EXTRACELLULAR MATRICES, 2023-2032 (IN $ MILLION)

FIGURE 17: GLOBAL 3D BIOPRINTING MARKET, BY OTHER BIOMATERIALS, 2023-2032 (IN $ MILLION)

FIGURE 18: GLOBAL 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2022

FIGURE 19: GLOBAL 3D BIOPRINTING MARKET, BY MAGNETIC LEVITATION BIOPRINTING, 2023-2032 (IN $ MILLION)

FIGURE 20: GLOBAL 3D BIOPRINTING MARKET, BY INKJET-BASED BIOPRINTING, 2023-2032 (IN $ MILLION)

FIGURE 21: GLOBAL 3D BIOPRINTING MARKET, BY SYRINGE/EXTRUSION-BASED BIOPRINTING, 2023-2032 (IN $ MILLION)

FIGURE 22: GLOBAL 3D BIOPRINTING MARKET, BY LASER-ASSISTED BIOPRINTING, 2023-2032 (IN $ MILLION)

FIGURE 23: GLOBAL 3D BIOPRINTING MARKET, BY OTHER TECHNOLOGIES, 2023-2032 (IN $ MILLION)

FIGURE 24: GLOBAL 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 25: GLOBAL 3D BIOPRINTING MARKET, BY DRUG TESTING & DEVELOPMENT, 2023-2032 (IN $ MILLION)

FIGURE 26: GLOBAL 3D BIOPRINTING MARKET, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, 2023-2032 (IN $ MILLION)

FIGURE 27: GLOBAL 3D BIOPRINTING MARKET, BY FOOD TESTING, 2023-2032 (IN $ MILLION)

FIGURE 28: GLOBAL 3D BIOPRINTING MARKET, BY RESEARCH, 2023-2032 (IN $ MILLION)

FIGURE 29: GLOBAL 3D BIOPRINTING MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 30: GLOBAL 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 31: GLOBAL 3D BIOPRINTING MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)

FIGURE 32: GLOBAL 3D BIOPRINTING MARKET, BY BIOPHARMACEUTICALS COMPANIES, 2023-2032 (IN $ MILLION)

FIGURE 33: GLOBAL 3D BIOPRINTING MARKET, BY RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, 2023-2032 (IN $ MILLION)

FIGURE 34: GLOBAL 3D BIOPRINTING MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)

FIGURE 35: NORTH AMERICA 3D BIOPRINTING MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 36: UNITED STATES 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 37: CANADA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 38: EUROPE 3D BIOPRINTING MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 39: UNITED KINGDOM 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 40: GERMANY 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: FRANCE 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: ITALY 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 43: SPAIN 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 44: NORDIC COUNTRIES 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 45: REST OF EUROPE 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 46: ASIA-PACIFIC 3D BIOPRINTING MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)

FIGURE 47: CHINA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 48: JAPAN 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 49: INDIA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 50: SOUTH KOREA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 51: SINGAPORE 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 52: THAILAND 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 53: AUSTRALIA & NEW ZEALAND 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 54: REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 55: REST OF WORLD 3D BIOPRINTING MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 56: LATIN AMERICA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FIGURE 57: MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

FAQs

Given the increasing innovations and the growing organ transplantation demands, China has the potential for exponential growth in the global 3D bioprinting market.

  • 3D bioprinting has played a vital role in pursuing a cure for the novel Coronavirus. Presently, bioprinting researchers are developing 3D bioprinted human micro-tissues, which can be infected with the SARS-CoV-2 virus, to study disease progression in a tissue setup. This closely mimics the native tissue micro-environment and physiology, thereby offering a lucrative opportunity to many biotechnology companies and researchers.

 Inkjet-based bioprinting dominates the global 3D bioprinting market.